Back to discover
Disease
Aspergillosis, Allergic Bronchopulmonary
Late-stage therapeutic developmentEmerging research
1
Publications
1
Clinical trials
2008
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2008-02-01Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
1
0
1
1
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Leading journals1
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America1
Leading researchers8
- Anaissie EJ1
- Denning DW1
- Herbrecht R1
- Kontoyiannis DP1
- Marr KA1
- Morrison VA1
- Patterson TF1
- Segal BH1
Affiliations (unnormalised)1
- National Cancer Institute1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Hypersensitivity reaction (ALLERGIC REACTION) to fungus ASPERGILLUS in an individual with long-standing BRONCHIAL ASTHMA. It is characterized by pulmonary infiltrates, EOSINOPHILIA, elevated serum IMMUNOGLOBULIN E, and skin reactivity to Aspergillus antigen.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.